(Total Views: 664)
Posted On: 04/27/2020 11:03:49 AM
Post# of 145249
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Kevzara/Sarilumab STUDY HALTED-No benefit seen... this will be the same for all IL6 blockers / arthritis medications... they don't even do that good of a job there, and secondary infections are rampant. Friend of mine in the ICU was in this study, currently with... you guessed it: bacterial infection.
https://www.wsj.com/articles/drug-study-halte...1587985203
Will be the same story for Actrema / Tocilizumab, with little doubt:
https://www.rheumatologyadvisor.com/home/topi...mab-in-ra/
https://www.wsj.com/articles/drug-study-halte...1587985203
Will be the same story for Actrema / Tocilizumab, with little doubt:
https://www.rheumatologyadvisor.com/home/topi...mab-in-ra/
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)